Grupo Empresas Matutes (investor - Corporate Investor)
See something wrong or missing? Let us know
Average round investment:4.03M USD
Average number per year:1.0
Distribution:
2024 (1)2023 (1)
Portfolio companies:
Laminar Pharma
Debos
Laminar Pharma
Debos
Mostly invests in:
Spain (2)
Biotech (1)
Spain (2)
Biotech (1)
2 tracked investments in:
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Investors with similar profile to Grupo Empresas Matutes
| Name | Criteria | |
|---|---|---|
![]() |
Advent France Biotechnology
83%
|
|
![]() |
CG Health Ventures
83%
|
|
![]() |
Good Growth Capital
83%
|
|
![]() |
SEAF
83%
|
|
![]() |
Unirisco Galicia
83%
|
|
![]() |
Barrabés
83%
|
|
![]() |
HEMAV
83%
|
|
![]() |
Abadía de Collado Hermoso
83%
|
|
![]() |
Antón Arriola
83%
|
|
![]() |
Beresford Ventures
83%
|
|


Belgium
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Italy
Portugal
United Kingdom